2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
39
Leukemia, Myeloid, Acute
35
Myelodysplastic Syndromes
33
Multiple Myeloma
30
Lymphoma, Non-Hodgkin
29
Hodgkin Disease
28
Graft vs Host Disease
26
Leukemia, Lymphocytic, Chronic, B-Cell
25
Lymphoma
24
Leukemia
24
Hematologic Neoplasms
20
Neoplasms
18
Lymphoma, Mantle-Cell
18
Sarcoma
17
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Breast Neoplasms
17
Tuberous Sclerosis
15
Myeloproliferative Disorders
15
Lymphoma, Large B-Cell, Diffuse
15
Lymphoma, Follicular
14
Burkitt Lymphoma
14
Waldenstrom Macroglobulinemia
13
Lymphoma, B-Cell, Marginal Zone
13
Recurrence
12
Neoplasm Metastasis
12
Carcinoma, Non-Small-Cell Lung
12
Prostatic Neoplasms
11
Primary Myelofibrosis
11
Melanoma
11
Leukemia, Myelomonocytic, Chronic
11
Interventions
Radiosurgery
6
Bevacizumab
5
Cochlear Implants
4
Gentamicins
3
Everolimus
3
Lapatinib
2
tozuleristide
1
neratinib
1
icotinib
1
gallium Ga 68 dotatate
1
brigatinib
1
Triamcinolone Acetonide
1
Temozolomide
1
Sufentanil
1
Sirolimus
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Mn-PyC3A
1
Microsurgery
1
Methylprednisolone
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Head Movements
1
HDAC-42
1
Fluoresceins
1
Fluorescein
1
Exome
1
Endostatins
1
Endoscopes
1
Docosahexaenoic Acids
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroma, Acoustic
×
Sirolimus
×
Clear all
NCT01490476
2017-05-23
AFINF2
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
10 enrolled